A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice-Reference-Cited by-同舟云学术

A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice

Published:2017-05 Issue: Volume:89 Page:1467-1475
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Li Zhixin,Fang Jinzhi,Jiao Rui,Wei Xiaomin,Ma Yanjie,Liu Xiaoran,Cheng Peng,Li Taiming

Funder

National College Students Innovation Project for the R&D of Novel Drugs

Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD]

Research Innovation Program for Graduates of Jiangsu Province

Top-notch Academic Programs Project of Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference49 articles.

1. Type 1 diabetes: new perspectives on disease pathogenesis and treatment;Atkinson;Lancet,2001

2. insulin-dependent diabetes mellitus;Tisch;Cell,1996

3. Translational mini-review series on type 1 diabetes: immune-based therapeutic approaches for type 1 diabetes;Staeva-Vieira;Clin. Exp. Immunol.,2007

4. Autoantigen based vaccines for type 1 diabetes;Nicholas;Discov. Med.,2011

5. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY);Barker;J. Clin. Endocrinol. Metab.,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current progress in the development of prophylactic and therapeutic vaccines;Science China Life Sciences;2022-12-02

2. Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases;Peptides;2022-09

3. Vaccine for Diabetes—Where Do We Stand?;International Journal of Molecular Sciences;2022-08-22

4. SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19;Metabolism Open;2021-12

5. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?;Frontiers in Pharmacology;2020-08-07